Skip to main content

Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions.

Schechter, C. B., & Mandelblatt, J. (2021). Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions. Journal of Clinical Oncology, 39(26), 2893-2902. https://doi.org/10.1200/jco.21.00651

Page updated April 9, 2025 | published January 1, 2021

Subscribe to NIMHD Email

 

Choose the topics right for you to get details on NIMHD research, funding opportunities, programs, training, events, resources and news directly to your inbox.